| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | HoxA13_N | 1.14e-04 | 4 | 82 | 2 | PF12284 | |
| Domain | HoxA13_N | 1.14e-04 | 4 | 82 | 2 | IPR022067 | |
| Domain | JMJC | 3.69e-04 | 32 | 82 | 3 | PS51184 | |
| Domain | JmjC_dom | 3.69e-04 | 32 | 82 | 3 | IPR003347 | |
| Domain | JmjC | 4.05e-04 | 33 | 82 | 3 | SM00558 | |
| Domain | - | 1.44e-03 | 13 | 82 | 2 | 2.10.10.10 | |
| Domain | TPR_8 | 1.63e-03 | 53 | 82 | 3 | PF13181 | |
| Domain | FN_type2_col-bd | 1.67e-03 | 14 | 82 | 2 | IPR000562 | |
| Domain | FN2_2 | 1.67e-03 | 14 | 82 | 2 | PS51092 | |
| Domain | fn2 | 1.67e-03 | 14 | 82 | 2 | PF00040 | |
| Domain | FN2_1 | 1.67e-03 | 14 | 82 | 2 | PS00023 | |
| Domain | FN2 | 1.67e-03 | 14 | 82 | 2 | SM00059 | |
| Domain | - | 3.76e-03 | 71 | 82 | 3 | 4.10.45.10 | |
| Pathway | REACTOME_REGULATION_OF_NF_KAPPA_B_SIGNALING | 5.80e-05 | 17 | 64 | 3 | MM15702 | |
| Pathway | REACTOME_REGULATION_OF_NF_KAPPA_B_SIGNALING | 6.94e-05 | 18 | 64 | 3 | M45023 | |
| Pubmed | An H-YDb epitope is encoded by a novel mouse Y chromosome gene. | 5.90e-06 | 2 | 85 | 2 | 8944031 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 20554760 | ||
| Pubmed | Analysis of ubiquitin E3 ligase activity using selective polyubiquitin binding proteins. | 5.90e-06 | 2 | 85 | 2 | 22721718 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 23912277 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 18434530 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 27533081 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 32963272 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 36833285 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 15758204 | ||
| Pubmed | Lysine demethylases KDM6A and UTY: The X and Y of histone demethylation. | 5.90e-06 | 2 | 85 | 2 | 31097364 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 29526794 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 10935549 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 23704979 | ||
| Pubmed | Correlation of Musashi-1, Lgr5, and pEGFR expressions in human small intestinal adenocarcinomas. | 1.77e-05 | 3 | 85 | 2 | 25773390 | |
| Pubmed | Lrig1 controls intestinal stem-cell homeostasis by negative regulation of ErbB signalling. | 1.77e-05 | 3 | 85 | 2 | 22388892 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 9499428 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 25448158 | ||
| Pubmed | TRIM25 regulates oxaliplatin resistance in colorectal cancer by promoting EZH2 stability. | 1.77e-05 | 3 | 85 | 2 | 33966039 | |
| Pubmed | Cloning genes encoding receptors related to chemoattractant receptors. | 1.77e-05 | 3 | 85 | 2 | 9653656 | |
| Pubmed | EGFR transcriptionally upregulates UTX via STAT3 in non-small cell lung cancer. | 1.77e-05 | 3 | 85 | 2 | 34661759 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 21940676 | ||
| Pubmed | Stem cell function and stress response are controlled by protein synthesis. | 1.77e-05 | 3 | 85 | 2 | 27306184 | |
| Pubmed | EGFR phosphorylation of DCBLD2 recruits TRAF6 and stimulates AKT-promoted tumorigenesis. | 3.53e-05 | 4 | 85 | 2 | 25061874 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 18317468 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 33826887 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 24005813 | ||
| Pubmed | Epidermal growth factor modulates tyrosine phosphorylation of a novel tensin family member, tensin3. | 3.53e-05 | 4 | 85 | 2 | 15140944 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 9854018 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 32820146 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 29326710 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 32732223 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 10767340 | ||
| Pubmed | KLF4 deletion alters gastric cell lineage and induces MUC2 expression. | 3.53e-05 | 4 | 85 | 2 | 27277677 | |
| Pubmed | Reversible ubiquitination shapes NLRC5 function and modulates NF-κB activation switch. | 5.87e-05 | 5 | 85 | 2 | 26620909 | |
| Pubmed | 5.87e-05 | 5 | 85 | 2 | 26573818 | ||
| Pubmed | 5.87e-05 | 5 | 85 | 2 | 20198339 | ||
| Pubmed | 5.87e-05 | 5 | 85 | 2 | 32538139 | ||
| Pubmed | 8.80e-05 | 6 | 85 | 2 | 30584065 | ||
| Pubmed | UTX Affects Neural Stem Cell Proliferation and Differentiation through PTEN Signaling. | 1.23e-04 | 7 | 85 | 2 | 29551674 | |
| Pubmed | 1.64e-04 | 8 | 85 | 2 | 29946151 | ||
| Pubmed | 1.64e-04 | 8 | 85 | 2 | 36412518 | ||
| Pubmed | Phospholipase C-related but catalytically inactive proteins regulate ovarian follicle development. | 1.64e-04 | 8 | 85 | 2 | 28360101 | |
| Pubmed | 2.10e-04 | 493 | 85 | 7 | 15368895 | ||
| Pubmed | UTX and UTY demonstrate histone demethylase-independent function in mouse embryonic development. | 2.10e-04 | 9 | 85 | 2 | 23028370 | |
| Pubmed | Reshuffling genomic landscapes to study the regulatory evolution of Hox gene clusters. | 2.10e-04 | 9 | 85 | 2 | 21670281 | |
| Pubmed | 2.10e-04 | 9 | 85 | 2 | 22949634 | ||
| Pubmed | IL-17R-EGFR axis links wound healing to tumorigenesis in Lrig1+ stem cells. | 2.10e-04 | 9 | 85 | 2 | 30578323 | |
| Pubmed | 2.10e-04 | 9 | 85 | 2 | 23563729 | ||
| Pubmed | Erk and MAPK signaling is essential for intestinal development through Wnt pathway modulation. | 2.11e-04 | 47 | 85 | 3 | 32747435 | |
| Pubmed | New insights into the role of Jmjd3 and Utx in axial skeletal formation in mice. | 2.54e-04 | 50 | 85 | 3 | 28188179 | |
| Pubmed | 2.62e-04 | 10 | 85 | 2 | 9328433 | ||
| Pubmed | 2.99e-04 | 130 | 85 | 4 | 12421765 | ||
| Pubmed | GINS3 EXO5 DNAAF10 UNC5B GAS7 NEIL3 TOMM40 POMT1 MBD4 ZNF583 PCM1 | 3.09e-04 | 1293 | 85 | 11 | 15342556 | |
| Pubmed | Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder. | 3.20e-04 | 11 | 85 | 2 | 20351715 | |
| Pubmed | SARM1 and TRAF6 bind to and stabilize PINK1 on depolarized mitochondria. | 3.20e-04 | 11 | 85 | 2 | 23885119 | |
| Pubmed | Tracing colonic embryonic transcriptional profiles and their reactivation upon intestinal damage. | 3.20e-04 | 11 | 85 | 2 | 34348153 | |
| Pubmed | In silico prediction of physical protein interactions and characterization of interactome orphans. | 3.54e-04 | 136 | 85 | 4 | 25402006 | |
| Pubmed | Genomic structure and chromosomal mapping of the murine and human Mbd1, Mbd2, Mbd3, and Mbd4 genes. | 4.52e-04 | 13 | 85 | 2 | 10441743 | |
| Pubmed | 4.52e-04 | 13 | 85 | 2 | 14660691 | ||
| Pubmed | Direct activation of protein kinases by unanchored polyubiquitin chains. | 4.52e-04 | 13 | 85 | 2 | 19675569 | |
| Pubmed | 4.52e-04 | 13 | 85 | 2 | 22192413 | ||
| Pubmed | Structural and chemical profiling of the human cytosolic sulfotransferases. | 4.52e-04 | 13 | 85 | 2 | 17425406 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | 4.96e-04 | 569 | 85 | 7 | 30639242 | |
| Pubmed | Stem cell-driven lymphatic remodeling coordinates tissue regeneration. | 5.27e-04 | 14 | 85 | 2 | 31672914 | |
| Pubmed | 5.27e-04 | 14 | 85 | 2 | 36639541 | ||
| Pubmed | 5.27e-04 | 14 | 85 | 2 | 15617687 | ||
| Pubmed | 5.27e-04 | 14 | 85 | 2 | 26553929 | ||
| Pubmed | 6.93e-04 | 16 | 85 | 2 | 27019864 | ||
| Pubmed | 6.93e-04 | 16 | 85 | 2 | 31092921 | ||
| Pubmed | Nipbl and mediator cooperatively regulate gene expression to control limb development. | 6.93e-04 | 16 | 85 | 2 | 25255084 | |
| Pubmed | KDM6B interacts with TFDP1 to activate P53 signaling in regulating mouse palatogenesis. | 6.93e-04 | 16 | 85 | 2 | 35212626 | |
| Pubmed | 6.93e-04 | 16 | 85 | 2 | 17520166 | ||
| Pubmed | 6.93e-04 | 16 | 85 | 2 | 20691176 | ||
| Pubmed | 6.93e-04 | 16 | 85 | 2 | 21752936 | ||
| Pubmed | Congenital Muscular Dystrophy Overview – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY | 7.84e-04 | 17 | 85 | 2 | 20301468 | |
| Pubmed | 8.02e-04 | 169 | 85 | 4 | 31462741 | ||
| Pubmed | 8.80e-04 | 18 | 85 | 2 | 19000668 | ||
| Pubmed | Mesenchymal-epithelial interaction regulates gastrointestinal tract development in mouse embryos. | 8.80e-04 | 18 | 85 | 2 | 35830795 | |
| Pubmed | Sex differences in sex chromosome gene expression in mouse brain. | 8.80e-04 | 18 | 85 | 2 | 12023983 | |
| Pubmed | A protein-protein interaction map of the TNF-induced NF-κB signal transduction pathway. | 8.89e-04 | 302 | 85 | 5 | 30561431 | |
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | 9.60e-04 | 462 | 85 | 6 | 31138677 | |
| Pubmed | 9.83e-04 | 19 | 85 | 2 | 16844427 | ||
| Pubmed | Cdx and Hox genes differentially regulate posterior axial growth in mammalian embryos. | 1.09e-03 | 20 | 85 | 2 | 19853565 | |
| Pubmed | 1.09e-03 | 20 | 85 | 2 | 19047629 | ||
| Pubmed | 1.09e-03 | 20 | 85 | 2 | 7738386 | ||
| Pubmed | A systematic, large-scale resequencing screen of X-chromosome coding exons in mental retardation. | 1.09e-03 | 20 | 85 | 2 | 19377476 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | IARS2 DYNC2H1 MRC2 SARM1 ARFGEF1 POMT1 TNFRSF21 RUSF1 ADGRG6 | 1.14e-03 | 1061 | 85 | 9 | 33845483 |
| Pubmed | 1.20e-03 | 21 | 85 | 2 | 15328023 | ||
| Pubmed | 1.20e-03 | 21 | 85 | 2 | 17303760 | ||
| Pubmed | 1.20e-03 | 21 | 85 | 2 | 32939012 | ||
| Pubmed | Genome-wide diet-gene interaction analyses for risk of colorectal cancer. | 1.20e-03 | 21 | 85 | 2 | 24743840 | |
| Pubmed | Genome-wide association study of ancestry-specific TB risk in the South African Coloured population. | 1.20e-03 | 21 | 85 | 2 | 24057671 | |
| Pubmed | Independent regulation of vertebral number and vertebral identity by microRNA-196 paralogs. | 1.32e-03 | 22 | 85 | 2 | 26283362 | |
| Pubmed | 1.32e-03 | 22 | 85 | 2 | 12768436 | ||
| Pubmed | 1.32e-03 | 22 | 85 | 2 | 25079229 | ||
| Pubmed | SAMM50 acts with p62 in piecemeal basal- and OXPHOS-induced mitophagy of SAM and MICOS components. | 1.32e-03 | 22 | 85 | 2 | 34037656 | |
| Pubmed | 1.35e-03 | 332 | 85 | 5 | 37433992 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | KIF13B TRAF6 METTL9 MYO5B DYNC2H1 DNAAF10 IQCB1 PLCL2 PRPF8 RUSF1 | 1.43e-03 | 1321 | 85 | 10 | 27173435 |
| Pubmed | Functional roles of Lgr4 and Lgr5 in embryonic gut, kidney and skin development in mice. | 1.44e-03 | 23 | 85 | 2 | 24680895 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 1.55e-03 | 202 | 85 | 4 | 33005030 | |
| Interaction | FBXO2 interactions | COLEC12 SULF2 TRIM25 EGFR ADAM23 MRC2 UNC5B IQCB1 POMT1 HPSE ADGRG6 | 7.48e-07 | 411 | 81 | 11 | int:FBXO2 |
| GeneFamily | DNA glycosylases | 7.07e-04 | 11 | 66 | 2 | 1024 | |
| GeneFamily | Sulfotransferases, cytosolic | 1.16e-03 | 14 | 66 | 2 | 762 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | ZNF430 SULF2 ITSN2 TRIM63 ARFGEF1 HAUS3 HAS2 MBD4 ELSPBP1 PCM1 SACM1L | 6.99e-06 | 656 | 83 | 11 | M18979 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_500 | 2.04e-06 | 385 | 81 | 10 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_1000 | PTN COLEC12 SULF2 EGFR MYO5B DYNC2H1 MRC2 THSD7B LGR5 KDM6A TSPAN5 ZFPM2 TNS3 | 7.82e-06 | 783 | 81 | 13 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_1000 | PTN COLEC12 SULF2 KRT24 EGFR MYO5B THSD7B MPZL2 LGR5 HPSE TSPAN5 ZFPM2 TNS3 | 9.45e-06 | 797 | 81 | 13 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_500 | 1.21e-05 | 372 | 81 | 9 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_500 | 6.53e-05 | 357 | 81 | 8 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#3_top-relative-expression-ranked_500 | 8.21e-05 | 116 | 81 | 5 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k3_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_1000 | PTN COLEC12 SULF2 EGFR MYO5B GAS7 THSD7B HAS2 LGR5 UTY ZFPM2 TNS3 | 8.63e-05 | 849 | 81 | 12 | gudmap_dev gonad_e11.5_M_GonMes_Sma_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000 | PTN COLEC12 SULF2 EGFR MYO5B THSD7B LGR5 KDM6A TSPAN5 ZFPM2 TNS3 | 1.12e-04 | 740 | 81 | 11 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | 1.86e-04 | 311 | 81 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K4 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000 | PTN COLEC12 SULF2 KRT24 EGFR MYO5B THSD7B LGR5 TSPAN5 ZFPM2 TNS3 | 2.15e-04 | 797 | 81 | 11 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_k-means-cluster#3_top-relative-expression-ranked_200 | 2.23e-04 | 31 | 81 | 3 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_k3_200 | |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_k-means-cluster#2_top-relative-expression-ranked_500 | 2.57e-04 | 148 | 81 | 5 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_k2_500 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla-lymphatic_endothelial_cell_of_renal_medulla|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.38e-07 | 164 | 85 | 6 | a784f47f67a5eda84d58ad7d9400e3978edbb487 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.38e-07 | 164 | 85 | 6 | 1a1795969673232191425dde84ab24ee6a98143f | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.38e-07 | 164 | 85 | 6 | 8f074940afdbda88a4b697a7ddc687e09a4b818b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.10e-07 | 170 | 85 | 6 | 6035c92cd39c5ac54e7ec57d94888ee19f574639 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.10e-07 | 170 | 85 | 6 | c8c42eda44b61440c96b202e7f54650046eb95d3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla-lymphatic_endothelial_cell_of_renal_medulla|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.10e-07 | 170 | 85 | 6 | dcc64b73134e89ae37990d4878813b86ce91dae9 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-proerythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.74e-07 | 172 | 85 | 6 | cfcfa7eeff1805bedf10a3c07826459914c3e872 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-06 | 178 | 85 | 6 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.58e-06 | 187 | 85 | 6 | e35716f8b482be3bf5ab79f087a9caf67a9d197a | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-06 | 187 | 85 | 6 | 65d406122dffe18279f14a1ed35ba091730b97be | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-06 | 187 | 85 | 6 | 4c15c0ed41a55271fc793cb76fee97fa64190369 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-06 | 187 | 85 | 6 | 5274f2b302bbf7fed30c480af4f35058d2cf61e0 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-06 | 190 | 85 | 6 | 1121eb607a984c59fbffe7220837fc178745aa55 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-06 | 190 | 85 | 6 | 048b581e3f7ea9fc2f87c0532974bba85c7292c2 | |
| ToppCell | Control-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class | 1.74e-06 | 190 | 85 | 6 | 4e30155203b4a8c5e496fcbe9348b67b98ebc625 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.90e-06 | 193 | 85 | 6 | 9ba688b35a9ead5d04691b3f3f15484f02dbbd0d | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.96e-06 | 194 | 85 | 6 | 4579b4a44f7c731553a284843c296866027d7c0e | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 2.02e-06 | 195 | 85 | 6 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | PCW_07-8.5-Mesenchymal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.08e-06 | 196 | 85 | 6 | 8e10802f52e5e1853ea4ad34bf9a32a34e6112b5 | |
| ToppCell | facs-Brain_Non-Myeloid|facs / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-06 | 197 | 85 | 6 | a1f7eec1aca03432caa8fe817ff6d24b29d4062d | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.14e-06 | 197 | 85 | 6 | b0036cf3f7e6edf8e43f16cd2f0f0e80471d2576 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-06 | 198 | 85 | 6 | a860246bcea847249a78fd2e86ed8e04371060db | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_VISp_Col8a1_Rxfp1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.27e-06 | 131 | 85 | 5 | 81efe8b0ca4377e557a42ddb12aecaf3f46b15bf | |
| ToppCell | COVID-19-kidney-Lymphatic_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.55e-06 | 148 | 85 | 5 | f777aa1674e898e2594b2b7c029d3d05dda04df9 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_ALM_Cpa6|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.16e-05 | 154 | 85 | 5 | 12cbc38bc1f7231c67e1d2d5e86e95bc12e24682 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-05 | 156 | 85 | 5 | dd41ed918b07fa248da458a629b3c53cb7ea8764 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-05 | 156 | 85 | 5 | abf9dd075b1ca8f613c660cc82f8a5af071fb6ab | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-05 | 159 | 85 | 5 | 330ecbba97d47bc818a5e8d1d84b05d056bd831e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-05 | 159 | 85 | 5 | cbb331eb689d8cea9e1146ba85e0a05d23301c47 | |
| ToppCell | facs-Spleen-nan-3m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-05 | 161 | 85 | 5 | 45591addc765760db6029ac19e80573373d1d917 | |
| ToppCell | facs-Spleen-nan-3m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-05 | 161 | 85 | 5 | 8741b91a62c9a8ce377ef6533d323b65beb93c63 | |
| ToppCell | facs-Spleen-nan-3m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-05 | 161 | 85 | 5 | 9cf1dcf0e7ca9e35c46c094a6b78f98d1f6b9276 | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.62e-05 | 165 | 85 | 5 | 570483b43ccb5831feec9337b4664814431d40b1 | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_TIP|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.62e-05 | 165 | 85 | 5 | 2026a9a07f4d314cc05c167e491312b373468e46 | |
| ToppCell | COVID-19-kidney-Lymphatic_EC|kidney / Disease (COVID-19 only), tissue and cell type | 1.71e-05 | 167 | 85 | 5 | 97d0fea1f41c1c00e36d9b5c4c1f0dd85087056f | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-05 | 168 | 85 | 5 | 0e8b0e6399c6c82c9c0e546f7316f902de0765d3 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-05 | 171 | 85 | 5 | ab21f20ec041cbaacccbd7da4dccdb77ec8bc5c6 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-05 | 171 | 85 | 5 | 97ad2cfff568a9d006ab1d2e6e00946ee4e3beb3 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_vein|Adult / Lineage, Cell type, age group and donor | 2.20e-05 | 176 | 85 | 5 | 043683c61c5d1a7f8a4666a612310246bd3d83a2 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.26e-05 | 177 | 85 | 5 | 227d4f423b00be2e0c5797e2c5275d342e69a0f4 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.26e-05 | 177 | 85 | 5 | 66ffa279147961080c104242a08b176e301d80e3 | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 2.26e-05 | 177 | 85 | 5 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.26e-05 | 177 | 85 | 5 | 0cbf54608d2ba0a0500af142f2029fe5e118c3c2 | |
| ToppCell | FF-Differ-KC|World / shred by cell class for mouse tongue | 2.39e-05 | 179 | 85 | 5 | 1526a130565a97c291a25a7a988089bffc1515c1 | |
| ToppCell | LA-01._Fibroblast_I|LA / Chamber and Cluster_Paper | 2.39e-05 | 179 | 85 | 5 | dcb6ec9ae72b13fe388b72dace2815293fafe8ee | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.45e-05 | 180 | 85 | 5 | cfc8bfbfd3617aabbb49f9730c29b673ca157e74 | |
| ToppCell | facs-SCAT|facs / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.45e-05 | 180 | 85 | 5 | 6c70b6b7480507fa94625013222ad338ee7dd1d9 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.45e-05 | 180 | 85 | 5 | 27e8bbee388e64dd79d70b160b76d45b1f398006 | |
| ToppCell | Control-Myeloid-DC1|Control / Condition, Lineage and Cell class | 2.52e-05 | 181 | 85 | 5 | 5a2a1f017ad23baed9972c68b4a46f4c618ef21a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.59e-05 | 182 | 85 | 5 | 41b070085edba7a58b81c20aa4942d06f745acf8 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.59e-05 | 182 | 85 | 5 | 5e9a67b2de0daa4fdc344b10a857d8a901ad810e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.59e-05 | 182 | 85 | 5 | b0fe042c71d6ab8c75abd7ba9d2de00b72d01c0c | |
| ToppCell | Control-Myeloid-DC1|Myeloid / Condition, Lineage and Cell class | 2.73e-05 | 184 | 85 | 5 | b5c1f57f0356969cfb0e1dac764684fc5583bc04 | |
| ToppCell | Control-Endothelial-Endothelial-Vein|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.87e-05 | 186 | 85 | 5 | 92092f11ecce22c14f244e42c499af0822977e6f | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.02e-05 | 188 | 85 | 5 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | COVID-19-lung-Vein_EC|lung / Disease (COVID-19 only), tissue and cell type | 3.02e-05 | 188 | 85 | 5 | d582b76fc2faac526c9bf97503041129e1a6a211 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.02e-05 | 188 | 85 | 5 | 26915db8863f4115b46a81982e187322e21600fd | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.02e-05 | 188 | 85 | 5 | 3f76c0f912f8f023ea425be7f43593b3d7f967e3 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.02e-05 | 188 | 85 | 5 | 61ee7b152745164293d8a44ef91ee2393efbdca5 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.18e-05 | 190 | 85 | 5 | 876bd2eb9ed2624cb23bdcf6b989e4fa34d099e3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.18e-05 | 190 | 85 | 5 | 2306aa9dbeaef3be8484a5b236605de23cd75d4c | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.18e-05 | 190 | 85 | 5 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.18e-05 | 190 | 85 | 5 | 1f83f7f24288a3b9ab33c2e113e845dba96adc8a | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-05 | 190 | 85 | 5 | 719a5cecc3e8001ca9c38165258b5ff9c800713a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.18e-05 | 190 | 85 | 5 | be9f36127028f52ca5fc1b32ba15a6c26aad69ac | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.18e-05 | 190 | 85 | 5 | 09a8855901c3c9332dbaab3e40166485b696d0f1 | |
| ToppCell | COPD-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 3.26e-05 | 191 | 85 | 5 | ef16ad1c1cd2c0c0377957398c98775b62a81754 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 3.26e-05 | 191 | 85 | 5 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | IPF-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 3.34e-05 | 192 | 85 | 5 | e911e286da26202853f9650ba3cdefe5a5c9b585 | |
| ToppCell | COVID-19-lung-Lymphatic_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.34e-05 | 192 | 85 | 5 | cbe57cda44232b183821ac633b60a2668265e616 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.42e-05 | 193 | 85 | 5 | 7cd9671e0ac64f7f3607f564485c63abbb7e7a63 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.42e-05 | 193 | 85 | 5 | daefbfd3a3dd1351fbe94b9abfd807db44d56c24 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.42e-05 | 193 | 85 | 5 | 96c85b250d04b5f400512097d925061c6dc2906b | |
| ToppCell | Endothelial-endothelial_cell_of_vein|World / Lineage, Cell type, age group and donor | 3.51e-05 | 194 | 85 | 5 | 3cbd9622a68e89add90e589867d88c83c5a33476 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.51e-05 | 194 | 85 | 5 | bc945450b350f597c3ff910d3a14a533d90086a8 | |
| ToppCell | IPF-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class | 3.51e-05 | 194 | 85 | 5 | e8a9005963704286bcc50785bda8d7d63ec001b1 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.60e-05 | 195 | 85 | 5 | 81a98ebb0d43f416f9a8bba580531dc0cfea8f74 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.60e-05 | 195 | 85 | 5 | 3d6d3de8ada6dce3dc789c15b50cc066e7100496 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.69e-05 | 196 | 85 | 5 | 57df2a57b35be9851ac0b1e5731baa53052511f0 | |
| ToppCell | LPS_IL1RA_TNF|World / Treatment groups by lineage, cell group, cell type | 3.78e-05 | 197 | 85 | 5 | 0a6550dce156fc81f15b1e7830d331ca50d87d06 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.78e-05 | 197 | 85 | 5 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | distal-Endothelial-Vein-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.78e-05 | 197 | 85 | 5 | 3d71c93da4b88ebbd58e68ed3dbf610d4bcfc4f5 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.78e-05 | 197 | 85 | 5 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | tumor_Lung-Endothelial_cells-Lymphatic_ECs|Endothelial_cells / Location, Cell class and cell subclass | 3.78e-05 | 197 | 85 | 5 | a05237ee6d31d9eab491dd7007859d6285cf1424 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.78e-05 | 197 | 85 | 5 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-A_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.78e-05 | 197 | 85 | 5 | ec92d60f802c9d4bdf9877bed5c0a91a5a5ed5d0 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-A_(Artery)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.78e-05 | 197 | 85 | 5 | 7bec9c1bc8851064eb229324493b47a31201c83c | |
| ToppCell | severe-HLA-DR+_CD83+_Monocyte|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.87e-05 | 198 | 85 | 5 | a77f3440d7fb6a50066abc7e9ad59e83798ef13d | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.87e-05 | 198 | 85 | 5 | 9d61483b0decac2fe90045b3474843360b2c49b3 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 3.87e-05 | 198 | 85 | 5 | 0c4d2c68a42f8a9e964e2dd28092fe75f5216834 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.87e-05 | 198 | 85 | 5 | 12cd9f0bbad8dce5199ebfed1c4a8080710ca055 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.87e-05 | 198 | 85 | 5 | 52ddc1f1ed4ac4c3bac794c90b8feb03e3c221c4 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.87e-05 | 198 | 85 | 5 | bc9c9f2c87282b5ef8514773e065d2a6b5dde338 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.96e-05 | 199 | 85 | 5 | 3a4deea6e11a0555d27497b7c9983350797aac69 | |
| ToppCell | distal-Endothelial-Vein-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.96e-05 | 199 | 85 | 5 | f9fc0482d7ab11f2165b30cce3564b4ff87d61a6 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.96e-05 | 199 | 85 | 5 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | cellseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.96e-05 | 199 | 85 | 5 | 68412bc39639edc4045437d62548f7101b9f1989 | |
| ToppCell | Parenchymal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_pulmonary_venous|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.96e-05 | 199 | 85 | 5 | 15db14eff63d5edeced0738542d5fb739225511b | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.06e-05 | 200 | 85 | 5 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 4.06e-05 | 200 | 85 | 5 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 | |
| Drug | Mephenytoin [50-12-4]; Up 200; 18.4uM; PC3; HT_HG-U133A | 7.52e-06 | 196 | 83 | 7 | 5801_UP | |
| Drug | estradiol, USP; Down 200; 0.1uM; MCF7; HT_HG-U133A | 7.52e-06 | 196 | 83 | 7 | 5205_DN | |
| Drug | Dropropizine (R,S) [17692-31-8]; Down 200; 17uM; MCF7; HT_HG-U133A | 8.03e-06 | 198 | 83 | 7 | 5531_DN | |
| Drug | Kawain [500-64-1]; Up 200; 17.4uM; PC3; HT_HG-U133A | 8.03e-06 | 198 | 83 | 7 | 3670_UP | |
| Drug | Paromomycin sulfate [1263-89-4]; Up 200; 5.6uM; PC3; HT_HG-U133A | 8.30e-06 | 199 | 83 | 7 | 4595_UP | |
| Drug | Mephentermine hemisulfate [1212-72-2]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 8.58e-06 | 200 | 83 | 7 | 3425_UP | |
| Drug | Bindschedler's Green | 3.93e-05 | 3 | 83 | 2 | CID000069473 | |
| Drug | Securinine [5610-40-2]; Down 200; 18.4uM; HL60; HT_HG-U133A | 6.33e-05 | 187 | 83 | 6 | 2729_DN | |
| Drug | 15d-PGJ2; Down 200; 10uM; PC3; HG-U133A | 7.32e-05 | 192 | 83 | 6 | 446_DN | |
| Drug | Hemicholinium bromide [312-45-8]; Down 200; 7uM; PC3; HT_HG-U133A | 7.98e-05 | 195 | 83 | 6 | 6739_DN | |
| Drug | Bromperidol [10457-90-6]; Down 200; 9.6uM; HL60; HG-U133A | 7.98e-05 | 195 | 83 | 6 | 1723_DN | |
| Drug | Tadjakonine [11087-94-8]; Down 200; 7.4uM; MCF7; HT_HG-U133A | 7.98e-05 | 195 | 83 | 6 | 2820_DN | |
| Drug | Sulfamerazine [127-79-7]; Down 200; 15.2uM; PC3; HT_HG-U133A | 7.98e-05 | 195 | 83 | 6 | 3718_DN | |
| Drug | Diprophylline [479-18-5]; Down 200; 15.8uM; PC3; HT_HG-U133A | 8.21e-05 | 196 | 83 | 6 | 5063_DN | |
| Drug | Chlorambucil [305-03-3]; Up 200; 13.2uM; PC3; HT_HG-U133A | 8.21e-05 | 196 | 83 | 6 | 4523_UP | |
| Drug | 0173570-0000 [211245-44-2]; Up 200; 10uM; PC3; HT_HG-U133A | 8.21e-05 | 196 | 83 | 6 | 3690_UP | |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; HL60; HT_HG-U133A | 8.21e-05 | 196 | 83 | 6 | 2560_UP | |
| Drug | Hydrastine hydrochloride [5936-28-7]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 8.21e-05 | 196 | 83 | 6 | 2889_DN | |
| Drug | Nalidixic acid sodium salt hydrate; Up 200; 14.6uM; PC3; HT_HG-U133A | 8.21e-05 | 196 | 83 | 6 | 3668_UP | |
| Drug | 2-Chloropyrazine [14508-49-7]; Down 200; 35uM; MCF7; HT_HG-U133A | 8.21e-05 | 196 | 83 | 6 | 6227_DN | |
| Drug | Telenzepine dihydrochloride [147416-96-4]; Up 200; 9uM; MCF7; HT_HG-U133A | 8.44e-05 | 197 | 83 | 6 | 7419_UP | |
| Drug | Tiaprofenic acid [33005-95-7]; Down 200; 15.4uM; HL60; HT_HG-U133A | 8.44e-05 | 197 | 83 | 6 | 2492_DN | |
| Drug | Prochlorperazine dimaleate [84-02-6]; Up 200; 6.6uM; PC3; HT_HG-U133A | 8.44e-05 | 197 | 83 | 6 | 6664_UP | |
| Drug | Epitiostanol [2363-58-8]; Down 200; 13uM; MCF7; HT_HG-U133A | 8.68e-05 | 198 | 83 | 6 | 4788_DN | |
| Drug | Tridihexethyl chloride; Down 200; 11.4uM; HL60; HT_HG-U133A | 8.68e-05 | 198 | 83 | 6 | 2964_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 1000uM; MCF7; HT_HG-U133A | 8.68e-05 | 198 | 83 | 6 | 6969_UP | |
| Drug | Bucladesine sodium salt [16980-89-5]; Up 200; 7.8uM; PC3; HT_HG-U133A | 8.68e-05 | 198 | 83 | 6 | 5886_UP | |
| Drug | Naltrexone hydrochloride dihydrate [16676-29-2]; Down 200; 9.6uM; PC3; HT_HG-U133A | 8.68e-05 | 198 | 83 | 6 | 2047_DN | |
| Drug | Tetramisole hydrochloride [16595-80-5]; Up 200; 16.6uM; MCF7; HT_HG-U133A | 8.68e-05 | 198 | 83 | 6 | 2849_UP | |
| Drug | vinblastine sulfate; Down 200; 0.1uM; PC3; HT_HG-U133A | 8.68e-05 | 198 | 83 | 6 | 7556_DN | |
| Drug | Proguanil hydrochloride [637-32-1]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 8.92e-05 | 199 | 83 | 6 | 5506_DN | |
| Drug | PF-01378883-00 [351320-41-7]; Down 200; 10uM; PC3; HT_HG-U133A | 8.92e-05 | 199 | 83 | 6 | 6410_DN | |
| Drug | Torsemide [56211-40-6]; Down 200; 11.4uM; PC3; HT_HG-U133A | 8.92e-05 | 199 | 83 | 6 | 5057_DN | |
| Drug | beta- Belladonnine dichloroethylate [191355-47-2]; Down 200; 6uM; MCF7; HT_HG-U133A | 8.92e-05 | 199 | 83 | 6 | 2819_DN | |
| Drug | Sparteine (-) [90-39-1]; Up 200; 17uM; PC3; HT_HG-U133A | 8.92e-05 | 199 | 83 | 6 | 4568_UP | |
| Drug | Sulpiride [15676-16-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 8.92e-05 | 199 | 83 | 6 | 1467_DN | |
| Drug | Timolol maleate salt [26921-17-5]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 8.92e-05 | 199 | 83 | 6 | 5280_UP | |
| Drug | tamoxifen citrate; Up 200; 1uM; ssMCF7; HG-U133A | 9.17e-05 | 200 | 83 | 6 | 375_UP | |
| Drug | retinoic acid; Down 200; 1uM; PC3; HG-U133A | 9.17e-05 | 200 | 83 | 6 | 447_DN | |
| Drug | C14381 | 1.30e-04 | 5 | 83 | 2 | CID000177947 | |
| Drug | 1,7-naphthyridine | 1.30e-04 | 5 | 83 | 2 | CID000009209 | |
| Disease | Kabuki syndrome (implicated_via_orthology) | 2.17e-05 | 3 | 80 | 2 | DOID:0060473 (implicated_via_orthology) | |
| Disease | SPARC measurement | 4.34e-05 | 4 | 80 | 2 | EFO_0020748 | |
| Disease | Rectal Neoplasms | 1.51e-04 | 7 | 80 | 2 | C0034885 | |
| Disease | testican-3 measurement | 1.51e-04 | 7 | 80 | 2 | EFO_0802124 | |
| Disease | Rectal Carcinoma | 1.51e-04 | 7 | 80 | 2 | C0007113 | |
| Disease | interferon alpha/beta receptor 1 measurement | 2.58e-04 | 9 | 80 | 2 | EFO_0021850 | |
| Disease | serine protease 27 measurement | 4.71e-04 | 12 | 80 | 2 | EFO_0008280 | |
| Disease | C-C motif chemokine 17 measurement | 4.71e-04 | 12 | 80 | 2 | EFO_0008045 | |
| Disease | muscular dystrophy (is_implicated_in) | 9.61e-04 | 17 | 80 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | p-tau:beta-amyloid 1-42 ratio measurement | 1.20e-03 | 19 | 80 | 2 | EFO_0007709 | |
| Disease | diet measurement, colorectal cancer | 1.20e-03 | 19 | 80 | 2 | EFO_0008111, MONDO_0005575 | |
| Disease | body fat percentage, coronary artery disease | 1.93e-03 | 24 | 80 | 2 | EFO_0001645, EFO_0007800 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 1.98e-03 | 195 | 80 | 4 | DOID:1574 (implicated_via_orthology) | |
| Disease | retinitis pigmentosa (implicated_via_orthology) | 2.44e-03 | 27 | 80 | 2 | DOID:10584 (implicated_via_orthology) | |
| Disease | lumbar disc degeneration | 2.62e-03 | 28 | 80 | 2 | EFO_0004994 | |
| Disease | cerebral white matter volume change measurement, age at assessment | 2.62e-03 | 28 | 80 | 2 | EFO_0008007, EFO_0021499 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TRDNQCQYIWGTKAA | 606 | O75077 | |
| ADWNYCNILVKTNGS | 56 | Q6UXZ3 | |
| SCNVKGNVVDWQNDF | 326 | Q86SQ4 | |
| IFAQLYWCVQQDNEQ | 1481 | Q9Y6D6 | |
| KVTCQNNYAVSTNWE | 176 | Q49SQ1 | |
| FAEACNNATYVEVWN | 106 | Q96D70 | |
| GTVKNYETAVQFCWN | 56 | O60895 | |
| NDEVWNLSNVQQGKY | 286 | O95825 | |
| WNFNCQFFIKDLYQD | 1616 | Q9NZM3 | |
| YQFQAWGECDLNTAL | 101 | P21246 | |
| YQEKEFFDIWICANN | 501 | Q86VD1 | |
| LATQNWCELQTAYGK | 86 | Q9H790 | |
| LKGFQWEYQSAQCRV | 76 | Q96P67 | |
| KNGQFNYPWDVAVNS | 696 | Q2Q1W2 | |
| LQKDWDNFFTICNNF | 531 | Q8NG48 | |
| GSCINKRENWDEQAY | 226 | Q5T1H1 | |
| LGKEKQCNFFQWAEN | 581 | Q8TAT5 | |
| QSQGCIAVNFWYDME | 281 | P0C870 | |
| TWQGVEDNKNNCIVY | 161 | Q8WW38 | |
| EGYWGVLNDFCEKNN | 1171 | O15550 | |
| DCWTVAFGNAYNQEE | 166 | Q96MX6 | |
| NRWKNNCPFSADENY | 951 | Q15154 | |
| GKILNQTQDGAFCYW | 1226 | Q02817 | |
| NLNKWGLNIFCVSDY | 371 | P27815 | |
| LIYAGQWNDFQCEDV | 711 | Q5KU26 | |
| EFWKQYVDGDQCESN | 86 | P00740 | |
| QIWGETKCQNAEYKQ | 416 | Q2M2I5 | |
| WQNTGFQYDVISCLN | 196 | Q9H1A3 | |
| WIQFLNKCFQVQGQE | 976 | Q9UBG0 | |
| WKLQFDDNGTYTCQV | 111 | O60487 | |
| DSYCWAAVQQKNSLQ | 81 | Q96RD7 | |
| SYWQSQVNQDICKYG | 116 | Q9Y251 | |
| QQQVTCYPFKDVNNW | 361 | Q9Y6A1 | |
| SCAQIWAFYEEFQQG | 1126 | Q8NCM8 | |
| KDNIGSQYLLNWCVQ | 806 | P00533 | |
| DTYCGDVWNTNKRQN | 216 | Q96BQ5 | |
| CYLQFNLENETAQMW | 191 | Q8NGA4 | |
| VEDWYNQEFMGNQCS | 296 | Q92819 | |
| NGWNSQVYCTKDQPQ | 236 | P35453 | |
| KWFCGNVNEQNVLSE | 41 | Q68CZ6 | |
| SQNICQWIDLVFGYK | 3351 | Q99698 | |
| GNDSYRIFCVNEWKQ | 541 | O95243 | |
| NGWDSQVYCSKEQSQ | 221 | P31276 | |
| QWKFCETNEYGGNSL | 111 | Q96BH3 | |
| QAACLIQAYWKGFQT | 296 | Q15051 | |
| NAWADNANACAKQYA | 436 | Q9NTJ5 | |
| ERGQDWEQTQKIYNC | 131 | Q86X76 | |
| AFGVCENAYKISNQW | 481 | O75473 | |
| QKCLQDNEWNYTRAG | 591 | Q9GZY0 | |
| FWVQILEQNENGEYC | 991 | Q9NQT8 | |
| QESYLLCWDQSQNQV | 351 | Q96GQ5 | |
| DCLAQGWKQYQQRAF | 36 | Q96DX8 | |
| WGVLNDFCEKNNLNF | 1121 | O14607 | |
| GDWKNYFTVAQNEEF | 271 | Q6IMI6 | |
| VGSQWKDIYQFLCNA | 426 | O75509 | |
| FQTGQKGLNDFQCWE | 176 | Q9BRX5 | |
| EYENNVQCLKTWFET | 7026 | Q8NF91 | |
| DQAWQAQNYGEKSQQ | 411 | Q96NG3 | |
| CVDLYNQAQSKWFEE | 386 | O60861 | |
| SFQVQKYWEVCSFNE | 636 | Q9UPR0 | |
| EIQQKCGFSELYSWQ | 86 | Q9NSE4 | |
| KQGAACNVWYLNSVE | 1306 | Q68CZ2 | |
| TAGDWKNYFTVAQNE | 261 | O43704 | |
| KCANDIFQAANPYWT | 46 | Q969Q1 | |
| NWEQSFEYNECGKAF | 141 | P17032 | |
| NNENIVGYNNKKCWP | 1121 | Q6P2Q9 | |
| EVQTWLQQIGFSKYC | 416 | Q6SZW1 | |
| AQQCNGIYIWKIGNF | 346 | Q9Y4K3 | |
| IHYWEVELQKNNFCG | 511 | Q14258 | |
| KGVVFCYWFNRNDSQ | 131 | Q8TEQ6 | |
| NCGDNNGWSLQFDKY | 61 | Q9HBX9 | |
| WNKTVGYCQGFNILA | 331 | Q9Y2I9 | |
| QIYFKCNGEWVSQND | 76 | Q8IZJ1 | |
| EQNEISGRYSWNFQK | 76 | A0A0A6YYK7 | |
| RCQVQFYGLSENDEW | 231 | P0DTU4 | |
| QQSKFVNWQVDGEYR | 181 | O96008 | |
| NSYQCEECGKVFNWF | 231 | Q9H8G1 | |
| QNLIDFTQEYWQCCG | 141 | P62079 | |
| CESGNFSWINQKVNF | 1226 | Q9UI33 | |
| EKNNYNAWVFIGVAA | 36 | Q6PGP7 | |
| LNENCFQFQYNLTEW | 1176 | Q9C0I4 | |
| EQGQYLQQDANECWI | 191 | P54578 | |
| YQTACEQLGQKWQCV | 451 | Q8IWU5 | |
| DCQSEDWYKNQLGSQ | 121 | Q96ND8 | |
| CQTNSKTEDWGYLNE | 1311 | Q9ULV0 | |
| KHEVWGSNQNYICNT | 471 | O75113 |